Acta cardiologica最新文献_第3页

How important is the risk of medical malpractice litigations against cardiologists in Belgium? 在比利时，针对心脏病专家的医疗事故诉讼风险有多重要？

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-06-11 DOI: 10.1080/00015385.2025.2516943

Nathalie Meyten, Tom G Moreels

{"title":"How important is the risk of medical malpractice litigations against cardiologists in Belgium?","authors":"Nathalie Meyten, Tom G Moreels","doi":"10.1080/00015385.2025.2516943","DOIUrl":"10.1080/00015385.2025.2516943","url":null,"abstract":"Background: Medical malpractice litigations represent an increasing reality for clinical physicians. No malpractice claims data are available on cardiologists in Belgium.Aim: We calculated the number of malpractice claims against cardiologists in Belgium based on the annual reports of the Fund for Medical Accidents (FMA).Methods: FMA annual reports are available online in the public domain from 2012 onwards, and they were reviewed focussing on Cardiology.Results: A total of 6884 applications for malpractice litigations were filed through the FMA, resulting in a final decision for 3185 health providers between 2014 and 2023. In this 10 year period, claims were filed against 73 cardiologists, ranking them in the top 15 specialities at risk for malpractice litigations. There are currently 1237 practicing cardiologists in Belgium, indicating that the cumulative 10 year risk of malpractice litigation through the FMA alone is 6%. This is lower than expected based on data in the literature, showing that missed diagnosis (myocardial infarction) and complications of interventional cardiology procedures represent the most common types of malpractice litigations against cardiologists. Compared to Gastroenterology, another interventional speciality within the field of Internal Medicine, Belgian cardiologists seem less prone to malpractice litigations. A total of 92 claims were filed through the FMA on a total of 777 practicing gastroenterologists (12%; p < 0.001 Chi-square).Conclusions: Based on the FMA annual reports, Belgian cardiologists face only a moderate risk of malpractice litigations reaching 6% over a 10 year time period, as compared to 12% cumulative risk of gastroenterologists.","PeriodicalId":6979,"journal":{"name":"Acta cardiologica","volume":" ","pages":"703-708"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144273849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

About a "false-positive" case of elevated troponin levels: differential diagnosis. 关于一例肌钙蛋白水平升高的“假阳性”病例：鉴别诊断。

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-02-10 DOI: 10.1080/00015385.2025.2462438

Tana Berisha, Adriana Postolache, Laura Vrancken, François Jouret, Patrizio Lancellotti, Caroline Le Goff

引用次数: 0

Left ventricular compression from giant emphysematous bulla. 巨大肺气肿造成左心室压迫。

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-01-10 DOI: 10.1080/00015385.2025.2450954

Jean Philippe Henry, Maria-Luiza Luchian, Laurence Gabriel, Julien Higny, Olivier Xhaët, Benoit Robaye, Alin-Mihail Telbis, Fabian Demeure, Antoine Guedes, Martin Benoit

引用次数: 0

Empagliflozin in heart failure with preserved ejection fraction: from randomized trials to real-world evidence. 恩帕列净对保留射血分数的心力衰竭的治疗：从随机试验到真实世界的证据。

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-08-08 DOI: 10.1080/00015385.2025.2538386

Sebastiaan Dhont, Amrit Singh, Bram Swinnen, Kwinten Vandebergen, Vince Smolders, Evelyne Meekers, Wilfried Mullens, Pieter Martens, Philippe B Bertrand

{"title":"Empagliflozin in heart failure with preserved ejection fraction: from randomized trials to real-world evidence.","authors":"Sebastiaan Dhont, Amrit Singh, Bram Swinnen, Kwinten Vandebergen, Vince Smolders, Evelyne Meekers, Wilfried Mullens, Pieter Martens, Philippe B Bertrand","doi":"10.1080/00015385.2025.2538386","DOIUrl":"10.1080/00015385.2025.2538386","url":null,"abstract":"Background: The EMPEROR-Preserved clinical trial established empagliflozin as an effective therapy in heart failure with preserved ejection fraction (HFpEF), yet real-world validation in elderly, comorbid populations remain limited. We aimed to evaluate the clinical profile, tolerability, and outcomes of empagliflozin in a large Belgian HFpEF cohort.Methods: This retrospective, single-centre observational study of consecutive HFpEF patients (LVEF >50%) initiated on empagliflozin (10 mg daily) between April 2023 and April 2024. Baseline characteristics, clinical parameters, laboratory values, and outcomes were collected from electronic health records.Results: Of 798 screened patients, 577 were included (median age 82 years, 58% female). Atrial fibrillation (67%) and hypertension (78%) were highly prevalent. Empagliflozin use was associated with significant improvements in NYHA functional class (NYHA II: 56% to 77%, p < 0.001) and reduction in peripheral oedema (26% to 9%, p < 0.001). Modest reductions were observed in systolic blood pressure (131 to 130 mmHg, p = 0.017), heart rate (71 to 68 bpm, p = 0.004), body weight (76 to 75 kg, p < 0.001), and BMI (27.7 to 27.2 kg/m2, p < 0.001). Haemoglobin levels increased (p = 0.002), while renal function declined modestly without clinical sequelae. Treatment discontinuation occurred in 2.8% of patients, mainly due to genitourinary infections. During a median follow-up period of 16 months, the all-cause mortality rate was 6.9%.Conclusion: In real-world elderly and comorbid HFpEF population, empagliflozin was well tolerated and associated with improvements in congestion and functional status, supporting the external validity of randomised trial findings.","PeriodicalId":6979,"journal":{"name":"Acta cardiologica","volume":" ","pages":"730-735"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144797936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

30-year trends in incidence of acute STEMI and NSTEMI in the Belgian Province of Luxembourg. A long-term follow-up of the MONICA-BELLUX registry. 比利时卢森堡省急性STEMI和非STEMI发病率的30年趋势。MONICA-BELLUX注册的长期随访。

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-07-17 DOI: 10.1080/00015385.2025.2524233

Bernhard L Gerber, Ines Kyungu Mande, Sergio Rizzi, Christian Brohet, Erwin Schröder, Patrick Chenu, Annie Robert

{"title":"30-year trends in incidence of acute STEMI and NSTEMI in the Belgian Province of Luxembourg. A long-term follow-up of the MONICA-BELLUX registry.","authors":"Bernhard L Gerber, Ines Kyungu Mande, Sergio Rizzi, Christian Brohet, Erwin Schröder, Patrick Chenu, Annie Robert","doi":"10.1080/00015385.2025.2524233","DOIUrl":"10.1080/00015385.2025.2524233","url":null,"abstract":"Background: We sought to evaluate the temporal changes in the incidence of acute myocardial infarction (AMI) using a 30-year continuation of the WHO MONICA registry in Luxembourg, applying modern MI definitions (STEMI and NSTEMI).Methods: We reanalysed clinical records, biomarkers, ECGs, and angiograms of all suspected Type I and III AMI cases from 1985 to 2014 in the MONICA-BELLUX registry. Cases were classified according to modern criteria as STEMI, NSTEMI, or ischaemic sudden cardiac death. Statistical analyses assessed trends in AMI incidence by sex, age group, and AMI type.Results: A total of 6,786 AMI cases were identified, including 4,361 STEMI, 1,507 NSTEMI confirmed by coronary thrombosis, 616 suspected NSTEMI, and 394 type III infarcts. The overall AMI incidence decreased by 5.3 events per 100,000 inhabitants annually, from 314 per 100,000 in 1986 to 116 per 100,000 in 2014. This decline was driven mainly by a 3.8-fold reduction in STEMI. NSTEMI incidence initially decreased, then stabilised after 2004, with the STEMI-to-NSTEMI ratio converging by 2009. While women had 3.8 times lower incidence of AMI, trends were similar across both sexes and all age groups. Survival rates, lower in women and NSTEMI, improved with increased use of coronary angiography and revascularization.Conclusion: Over 30 years, AMI incidence, particularly STEMI, decreased threefold across all age groups and genders, while NSTEMI incidence initially declined but increased after 2000 due to improved diagnostic sensitivity with troponins, and survival rates improved with greater use of angiography and revascularization.","PeriodicalId":6979,"journal":{"name":"Acta cardiologica","volume":" ","pages":"709-720"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144648228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Belgian contributions to contemporary cardiovascular research: linking science, practice, and outcomes. 比利时对当代心血管研究的贡献：连接科学、实践和结果。

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-09-10 DOI: 10.1080/00015385.2025.2557142

Patrizio Lancellotti, Cécile Oury

引用次数: 0

Comment on: 'Volume challenge in women with congenital heart disease during reproductive age and pregnancy outcome' by K. VERHENNE et al. 评论：K. VERHENNE等人的“育龄期先天性心脏病女性的容积挑战和妊娠结局”。

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-08-05 DOI: 10.1080/00015385.2025.2520025

Marie-Christine Seghaye

引用次数: 0

Echocardiographic practices in pulmonary hypertension: survey results and literature review. 超声心动图在肺动脉高压中的应用：调查结果和文献综述。

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-06-17 DOI: 10.1080/00015385.2025.2518645

Patrizio Lancellotti, Werner Budts, Jean-Luc Vachiery

引用次数: 0

Cross-prevalence of large and small vessels disease in T2DM: overview from a Belgian academic centre. T2DM中大、小血管疾病的交叉流行：来自比利时学术中心的综述

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-06-27 DOI: 10.1080/00015385.2025.2524239

Fabian O Lurquin, Elise L Petit, Sylvie A Ahn, Michel F Rousseau, Michel P Hermans

{"title":"Cross-prevalence of large and small vessels disease in T2DM: overview from a Belgian academic centre.","authors":"Fabian O Lurquin, Elise L Petit, Sylvie A Ahn, Michel F Rousseau, Michel P Hermans","doi":"10.1080/00015385.2025.2524239","DOIUrl":"10.1080/00015385.2025.2524239","url":null,"abstract":"Aims: To document the cross-prevalence of overall macro- and microangiopathy in T2DM and identify common and vessel-size-specific variables associated with comorbidities.Methods: Cross-sectional study of 876 T2DM patients to assess frequency of macrovascular and microvascular target organ damage (TOD). Logistic regressions were performed to identify common and specific variables linked to TODs.Results: Overall prevalence of Mic and Mac were 41% and 33%, respectively; 45.5% had no comorbidities (Mic[-]Mac[-]); 21% had microangiopathy only (Mic[+]Mac[-]), 13.5% had macroangiopathy only (Mic[-]Mac[+]); 20% both (Mic[+]Mac[+]). Compared to Mic[-]Mac[-], the 3 TOD groups had more (micro)albuminuria. Mic[-]Mac[+] and Mic[+]Mac[+] had more diabetic foot (DF) and heart failure (HF) than Mic[-]Mac[-]. Mic[+]Mac[+] suffered more often from atrial fibrillation than Mic[-]Mac[-]. Mic[+]Mac[+] suffered twice more from peripheral artery disease and thrice higher DF, and 1.5 times more HF vs. Mic[-]Mac[+]. Non-HDL-C, remnant cholesterol, sleep apnoea and non-O blood group were associated with Mic/Mac.Conclusions: This transversal analysis provides quantitative data on cross-prevalence of micro- and macroangiopathies in a 3rd line hospital. Small and large-vessel diseases are highly intertwined with atherosclerotic, cardiometabolic and cardiorenal co-morbidities.","PeriodicalId":6979,"journal":{"name":"Acta cardiologica","volume":" ","pages":"721-729"},"PeriodicalIF":2.5,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144504375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cardiac angiosarcoma. Cardiac血管肉瘤。

IF 2.5 4区医学

Acta cardiologica Pub Date : 2025-09-01 Epub Date: 2025-03-21 DOI: 10.1080/00015385.2025.2480989

A Maiorana, P Lancellotti

引用次数: 0